Solitron Devices, Inc. (SODI)

Market Cap	34.26M
Revenue (ttm)	12.78M
Net Income (ttm)	-110.00K
Shares Out	2.08M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	379
Average Volume	1,405
Open	16.45
Previous Close	16.15
Day's Range	16.45 - 16.45
52-Week Range	14.00 - 18.64
Beta	0.81
RSI	51.54
Earnings Date	Jul 11, 2025

About Revance Therapeutics

Solitron Devices, Inc. designs, develops, manufactures, and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets in the United States, Canada, Latin America, Europe, and Australia. It offers a range of bipolar and metal oxide semiconductor (MOS) power transistors; power and control hybrids; junction and power MOS field effect transistors; field effect transistors; and other related products. The company also provides joint army/navy transistors, diodes, and standard military drawings ...

• Industry: Semiconductor Equipment & Materials
• Sector: Technology
• Founded: 1959
• Employees: 47
• Stock Exchange: OTCMKTS
• Ticker Symbol: SODI

Financial Performance

In 2024, Solitron Devices's revenue was $14.05 million, an increase of 10.13% compared to the previous year's $12.76 million. Earnings were $815,000, a decrease of -85.95%.